The federal government has heard and acknowledged the Foundation’s postcard campaign for increased funding.
We reviewed the results of the CATT study, designed to compare two drugs Lucentis (ranibizumab) and Avastin (bevacizumab) used to treat wet AMD.
The inaugural Macular Degeneration Foundation Research Grants Program awarded nearly three-quarters of a million dollars to support crucial macular disease research.
The 2011 Eyes on the Future report provides the most comprehensive compilation of macular degeneration statistics and research ever undertaken in Australia.
There is no compelling evidence-based research that hyperbaric oxygen treatment has a beneficial effect on AMD.
MDFA’s first ever mEYE World competition invited people to help raise awareness of AMD through photography.
The Macular Degeneration Foundation has established a Research Grants Program to raise $10 million over the next 10 years.
The Macular Degeneration Foundation is advocating for national subsidy scheme for low vision aids and technology for people with low vision.
Annastacia Palaszczuk was diagnosed with the wet form of macular degeneration when she was just 34 years of age.